Avita Medical Inc. Revenue 2018–2025
Avita Medical Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Avita Medical Inc. revenue for the quarter ending March 31, 2026 was 19.3 M, a 3.98% increase year-over-year.
- Avita Medical Inc. revenue for the twelve months ending March 31, 2026 was 73.2 M, a 23.12% increase year-over-year.
- Avita Medical Inc. annual revenue for 2025 was 71.6 M, a 11.45% increase from 2024.
- Avita Medical Inc. annual revenue for 2024 was 64.3 M, a 28.14% increase from 2023.
- Avita Medical Inc. annual revenue for 2023 was 50.1 M, a 45.68% increase from 2022.
- Avita Medical Inc. annual revenue for 2022 was 34.4 M.
Avita Medical Inc. (RCEL) — Frequently Asked Questions
Avita Medical Inc. (RCEL) is a publicly traded US company. It has a market capitalization of $115M. In fiscal 2025 it reported revenue of $72M and net income of -$49M. Explore RCEL's stock price, financial statements, earnings history, margins and key ratios below.
What is Avita Medical Inc.'s market cap?
Avita Medical Inc. (RCEL) has a market capitalization of $115M.
What is the RCEL stock price?
RCEL trades at $4.12.
How much revenue does Avita Medical Inc. make?
Avita Medical Inc. reported revenue of $72M in fiscal 2025.
Is RCEL profitable?
In fiscal 2025, Avita Medical Inc. reported net income of -$49M.